title: 11th Lorne Cancer Conference, Lorne, Victoria, Australia, 11-14th February 1999.
authors.affiliation: VBCRC Laboratory, The Walter and Eliza Hall Institute of Medical Research/Royal Melbourne Hospital, Melbourne, VIC, Australia. lindeman@wehi.edu.au
authors.forename: G J
authors.initials: GJ
authors.lastname: Lindeman
authors.forename: J E
authors.initials: JE
authors.lastname: Visvader
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017209:Apoptosis / Q000235:genetics; D002453:Cell Cycle / Q000235:genetics; D016207:Cytokines / Q000235:genetics / Q000627:therapeutic use; D017491:Genes, APC; D016147:Genes, Tumor Suppressor; D005821:Genetic Techniques; D006801:Humans; D009369:Neoplasms / Q000235:genetics* / Q000628:therapy; D016615:Telomere / Q000235:genetics; D000077704:Tirapazamine; D014227:Triazines / Q000627:therapeutic use; D009396:Wilms Tumor / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D016207:Cytokines; D014227:Triazines; D000077704:Tirapazamine